Deciphera Pharmaceuticals SG&A Expense (Quarterly) Trends

Deciphera Pharmaceuticals Inc (DCPH)

25.46 +0.02 (+0.06%) USD | NASDAQ | May 17, 16:00

25.46 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	33.92M
December 31, 2023	39.15M
September 30, 2023	33.25M
June 30, 2023	32.61M
March 31, 2023	31.45M
December 31, 2022	32.20M
September 30, 2022	30.03M
June 30, 2022	29.62M
March 31, 2022	28.32M
December 31, 2021	37.15M
September 30, 2021	35.53M
June 30, 2021	32.83M
March 31, 2021	30.75M
December 31, 2020	30.07M
September 30, 2020	30.14M
June 30, 2020	29.93M

Date	Value
March 31, 2020	23.94M
December 31, 2019	23.74M
September 30, 2019	17.98M
June 30, 2019	13.16M
March 31, 2019	13.24M
December 31, 2018	6.474M
September 30, 2018	5.259M
June 30, 2018	4.453M
March 31, 2018	5.026M
December 31, 2017	4.68M
September 30, 2017	2.43M
June 30, 2017	2.244M
March 31, 2017	2.067M
December 31, 2016	1.997M
September 30, 2016	1.35M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

13.16M

Minimum

Jun 2019

39.15M

Maximum

Dec 2023

29.79M

Average

30.44M

Median

SG&A Expense (Quarterly) Benchmarks